Calcium, phosphorus, PTH and death rates in a large sample of dialysis patients from Latin America. The CORES Study
- 31 May 2010
- journal article
- research article
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 26 (6), 1938-1947
- https://doi.org/10.1093/ndt/gfq304
Abstract
Background. Mineral metabolism parameters may play a role in the survival of patients with chronic kidney disease (CKD). Methods. In the CORES Study, we analysed the association between calcium, phosphorus and PTH and mortality (all-cause and cardiovascular) in 16 173 haemodialysis (HD) patients over 18 years from six Latin American countries, who underwent haemodialysis up to 54 months. Unadjusted, case-mix-adjusted and time-dependent multivariable-adjusted hazard ratio (HR) of death were calculated for categories of serum albumin-corrected calcium (Ca-Alb), phosphorus and PTH using as 'reference values' the range in which the lowest death rate was observed. Age, gender, vitamin D treatment, diabetes, vintage, vascular access, weight, blood pressure and laboratory variables (serum albumin, haemoglobin, creatinine, ferritin and Kt/V) were used as confounding variables. Results. Low (10.5 mg/dL) CaAlb increased the HR for all-cause mortality. Low (5.5 mg/dL) increased the HR for both all-cause and cardiovascular mortality. Low phosphorus (300 pg/mL) PTH increased the HR for both all-cause and cardiovascular mortality. In addition, only phosphorus >6.0 mg/dL increased the HR for cardiovascular hospitalizations. No effect was observed with Ca-Alb or PTH. Conclusions. In summary, in 16 173 HD patients, elevated and reduced serum levels of albumin-corrected calcium, phosphorus and PTH levels were associated with increments in all-cause mortality. Similar results were obtained when only cardiovascular mortality was analysed.This publication has 40 references indexed in Scilit:
- Phosphorus Binders and Survival on HemodialysisJournal of the American Society of Nephrology, 2009
- Systematic review of the evidence underlying the association between mineral metabolism disturbances and risk of all-cause mortality, cardiovascular mortality and cardiovascular events in chronic kidney diseaseNephrology Dialysis Transplantation, 2008
- Mortality Risk for Dialysis Patients With Different Levels of Serum Calcium, Phosphorus, and PTH: The Dialysis Outcomes and Practice Patterns Study (DOPPS)American Journal of Kidney Diseases, 2008
- Association of mineral metabolism factors with all‐cause and cardiovascular mortality in hemodialysis patients: The Japan dialysis outcomes and practice patterns studyHemodialysis International, 2007
- Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patientsKidney International, 2006
- Changes in serum calcium, phosphate, and PTH and the risk of death in incident dialysis patients: A longitudinal studyKidney International, 2006
- Influence of ultraviolet radiation on the production of 25 hydroxyvitamin D in the elderly population in the city of São Paulo (23 o 34’S), BrazilOsteoporosis International, 2005
- Predictors and consequences of altered mineral metabolism: The Dialysis Outcomes and Practice Patterns StudyKidney International, 2005
- Hypocalcemia, Morbidity, and Mortality in End-Stage Renal DiseaseAmerican Journal of Nephrology, 1996
- Increased Ionized Calcium and Left Ventricular Contractility during HemodialysisThe New England Journal of Medicine, 1984